Companies / United Kingdom
GSK Acquires US Consumer Health Firm CNS
October 2006 | Company News AlertIn an effort to expand its product offering and remain competitive with the major players, UK firm GlaxoSmithKline (GSK) has revealed that it is to acquire US consumer healthcare company CNS for $566mn. BMI believes that GSK got a good deal, considering it only paid a 31% premium to CNS' market capitalisation. Closure of the transaction is expected in early
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
